LINC01198 Activates Hippo Signaling to Stimulate IL-1β Autocrine for Driving Vemurafenib Resistance by Associating with TAOK1/2 in Melanoma

Scientists established vemurafenib-resistance melanoma cell strain together with acute vemurafenib treatment and characterized LINC01198 as the only one LncRNA up-regulated in both of stable vemurafenib-resistant and acute vemurafenib-treated melanoma cells.